bpc 157 townsend leter BPC-157 – Mark Hyman, MD Drug Discovery Targeting Post-Translational Modifications

Micronucleus testing revealed no clastogenic effects, indicating the peptide does not damage chromosomes

Standard dosing protocol (monotherapy) Week-by-week titration: Week 1-4: 0.6mg weekly Week 5-8: 1.2mg weekly Week 9-12: 1.8mg weekly Week 13+: 2.4mg weekly (maintenance) Why slow titration: Reduces nausea and GI side effects Allows body to adapt Better long-term adherence Standard in all trials Injection details: Subcutaneous injection Abdomen, thigh, or upper arm Weekly dosing (same day each week) Rotate injection sites Duration of use: Minimum 68 weeks for maximum results Often 12-18 months Maintenance indefinite (to prevent regain) No defined end point Use our peptide calculator , peptide dosing guide , peptide dosage chart , and how to calculate peptide dosages at SeekPeptides

The vehicle control receives only the reconstitution solvent without peptide

BPC-157 is one peptide

While he experienced recovery, he also didn't share the long-term effects